GlassScriptPhysician profile
Michael Andrew Granieri
NPI 1992095541
$71,006.17
in general payments reported to CMS, 2019-2025
38 companies · $14K in 2025
The $14K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,022 · 2020: $448 · 2021: $894 · 2022: $19K · 2023: $15K · 2024: $20K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Food and Beverage: $6,463 · Travel and Lodging: $5,333 · Consulting Fee: $1,975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $35,160.00 |
| Food and Beverage | $6,463.23 |
| Travel and Lodging | $5,333.26 |
| Consulting Fee | $1,975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $66,169.24 | 2019-2025 | Tactra, Advance Xp, General - Erectile Dysfunction |
| Astellas Pharma US INC | $620.44 | 2019-2025 | Myrbetriq, Xtandi |
| Ferring Pharmaceuticals INC. | $544.82 | 2019-2025 | Adstiladrin |
| Janssen Biotech, INC. | $348.73 | 2019-2025 | Erleada, Akeega, Balversa |
| Abbvie INC. | $323.72 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $321.54 | 2020-2023 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $167.07 | 2021-2025 | Provenge |
| Sumitomo Pharma America, INC. | $165.70 | 2023 | Orgovyx |
| Urogen Pharma, INC. | $158.72 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.12 | 2019-2023 | |
| Medtronic, INC. | $153.27 | 2023 | Interstim, Signia |
| Myovant Sciences INC. | $152.26 | 2022 | |
| Angiodynamics, INC. | $151.40 | 2024 | Nanoknife |
| Janssen Scientific Affairs, LLC | $149.84 | 2025 | Erleada |
| I/O Urology Corp. | $149.83 | 2024 | Carepath |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $145.16 | 2025 | Urolift |
| Tolmar, INC. | $127.61 | 2025 | |
| Neotract INC. | $117.92 | 2019 | |
| Pfizer INC. | $117.83 | 2019-2024 | |
| Medtronic USA, INC. | $82.59 | 2019 | |
| Blue Earth Diagnostics | $75.55 | 2021-2024 | |
| Coloplast Corp | $69.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $66.43 | 2020-2023 | |
| Axonics, INC. | $62.97 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $56.44 | 2024-2025 | Lynparza |
| Laborie Medical Technologies Corp. | $52.19 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Telix Pharmaceuticals | $47.66 | 2024-2025 | Illuccix |
| Endo USA, INC. | $44.23 | 2024 | Xiaflex |
| Sun Pharmaceutical Industries INC. | $34.15 | 2024 | |
| Travere Therapeutics, INC. | $33.16 | 2019-2021 | |
| Procept Biorobotics Corporation | $32.47 | 2024 | Aquabeam System |
| Alnylam Pharmaceuticals INC. | $26.33 | 2022 | |
| Amgen INC. | $24.46 | 2019-2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $15.00 | 2019 | |
| Accord Healthcare, INC. | $14.57 | 2025 | |
| Sandoz INC. | $14.33 | 2025 | Wyost, Jubbonti |
| Zyla Life Sciences, INC. | $13.26 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Granieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.